P
Praxis Precision Medicines
Developing therapies for central nervous system disorders based on genetic insights into neuronal imbalance
About Praxis Precision Medicines
Praxis Precision Medicines is a clinical stage biopharmaceutical company focused on developing therapies for central nervous system (CNS) disorders, particularly those characterized by neuronal imbalance. The company leverages insights from genetic epilepsies to create innovative treatments aimed at addressing unmet medical needs. Praxis operates in the biopharmaceutical market, primarily serving patients with CNS disorders and their caregivers. The business model revolves around patient-guided development strategies, ensuring that the therapies developed are aligned with what patients actually need. Revenue is generated through the development and potential commercialization of these therapies, as well as through partnerships and collaborations with other entities in the healthcare sector.
Source: Dealroom company dataAt a glance
- Founded
- 2015
- Headquarters
- Cambridge, United States
- Listing
- IPO 2020
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tier
Latest news
Press, funding announcements and product moves mentioning Praxis Precision Medicines.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later14 investors entered at this stage
Eventide Asset Management
Qatar Investment Authority
Point72 Ventures
Citadel
Blackstone
Adage Capital
Novo Holdings
Cormorant Asset Management
Vida Ventures- IIIrving Investors
OCV Partners
Avoro Capital Advisors- VMVerition Fund Management
Affinity Asset Advisors
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
49 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Praxis Precision Medicines on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Praxis Precision Medicines on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.